Zacks Investment Research on MSN13 天
New Product Launches Benefit GMED Stock Amid Macro Issues
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, the challenging macroeconomic scenario continues to plague Globus Medical. The stock ...
Globus Medical GMED has entered into a definitive agreement to acquire Nevro Corp ... fueled by the strong performance of its implantable devices, biologics, accessories and unique surgical ...
StockNews.com began coverage on shares of Nevro (NYSE:NVRO – Free Report) in a report published on Saturday morning. The brokerage issued a hold rating on the medical equipment provider’s stock.
At close: March 24 at 4:00:02 p.m. EDT Loading Chart for NVRO ...
REDWOOD CITY, Calif. (AP) — REDWOOD CITY, Calif. (AP) — Nevro Corp. (NVRO) on Tuesday reported a loss of $53.1 million in its fourth quarter. On a per-share basis, the Redwood City ...
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.